Adenosine Deaminase 2 Deficiency with a Novel Variant of CECR1 Gene Mutation: Responding to Tumor Necrosis Factor Antagonist Therapy

Adenosine Deaminase 2 Deficiency with a Novel Variant of CECR1 Gene Mutation: Responding to Tumor Necrosis Factor Antagonist Therapy